The role of the NFAT signaling pathway in retinal neovascularization

Colin A Bretz1, Sara Savage, Megan Capozzi

  • 1Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.

Abstract

Insights

Nuclear factor of activated T cells (NFAT) signaling drives angiogenic behaviors in human retinal cells. Inhibiting NFAT effectively reduces abnormal blood vessel growth in oxygen-induced retinopathy, suggesting NFAT as a therapeutic target for neovascular eye diseases.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cell Biology

Background:

  • Vascular Endothelial Growth Factor (VEGF) signaling is crucial for angiogenesis.
  • The transcription factor Nuclear Factor of Activated T cells (NFAT) is activated downstream of VEGF.
  • NFAT's role in the angiogenic cell behaviors of human retinal microvascular endothelial cells (HRMEC) requires further investigation.

Purpose of the Study:

  • To investigate the role of NFAT in the angiogenic cell behaviors of HRMEC.
  • To assess the efficacy of NFAT signaling inhibitors in a rat model of oxygen-induced retinopathy (OIR).

Main Methods:

  • HRMEC were treated with VEGF and the NFAT inhibitor INCA-6; NFAT translocation was assessed via immunocytochemistry.
  • HRMEC proliferation and tube formation were evaluated after treatment with varying doses of INCA-6.
  • Rats with OIR received INCA-6 or FK-506 (a calcineurin inhibitor); retinal neovascular area was measured.

Main Results:

  • VEGF induced NFATc1 translocation to the nucleus in HRMEC, which was blocked by INCA-6.
  • INCA-6 inhibited HRMEC proliferation and tube formation in a dose-dependent manner.
  • Both INCA-6 and FK-506 significantly reduced pathologic neovascularization in the OIR model.

Conclusions:

  • NFATc1 activation downstream of VEGF signaling plays a key role in HRMEC angiogenic behaviors.
  • NFAT inhibition demonstrates high efficacy in an OIR model.
  • The NFAT signaling pathway represents a potential therapeutic target for neovascular eye diseases.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...